Skip to main content
. 2018 Sep 4;2018(9):CD013102. doi: 10.1002/14651858.CD013102

Armour 2007.

Methods Randomised trial
Participants 396 asthma patients (intervention 191; control 205)
Recruited from 50 pharmacies
New South Wales, Queensland and Victoria, Australia.
Year of study: November 2004 to July 2005
Interventions Pharmacy Asthma Care Program intervention included targeted counselling and asthma education, medication and lifestyle issues, review of inhaler technique, drug‐related problems, goal setting and review, and possible GP referral. This was developed through 3 visits across a 6‐month period, plus an optional visit at 3 months.
Outcomes Forced Expiratory Volume (FEV1) at 6 months
Mean change in FEV1 from baseline
Asthma severity at 6 months
Notes Funding source: Australian Department of Health and Ageing as part of the Third Community Pharmacy Agreement.
Conflict of interest: None stated.
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Unclear risk Method of randomisation not stated
Allocation concealment (selection bias) Low risk Quote: "Pharmacists were not informed as to group allocation; both groups were informed that they were providing an asthma care service involving spirometry. Pharmacies were asked to recruit up to 10 subjects from their customers."
Blinding of participants and personnel (performance bias) 
 All Outcomes/Outcome 1 Low risk Quote: "Pharmacists were not informed as to group allocation; both groups were informed that they were providing an asthma care service involving spirometry."
Blinding of outcome assessment (detection bias) 
 All Outcomes/Outcome 1 High risk Participants were unblinded and this may have influenced measurement of FEV.
Incomplete outcome data (attrition bias) 
 All outcomes Low risk Between group attrition < 10%. Overall competion rate 91%.
Selective reporting (reporting bias) Low risk All outcomes reported
Other bias Low risk None identified